文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

风险 SNP 诱导的长链非编码 RNA-SLCC1 通过激活糖酵解信号通路驱动结直肠癌。

Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling.

机构信息

State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Renji Hospital, Shanghai Jiao Tong University School of Medicine, 145 Middle Shandong Road, 200001, Shanghai, China.

Key Laboratory of Exploration and Utilization of Aquatic Genetic Resources, Ministry of Education, College of Fishery and Life Science, Shanghai Ocean University, Shanghai, 201306, China.

出版信息

Signal Transduct Target Ther. 2021 Feb 19;6(1):70. doi: 10.1038/s41392-020-00446-7.


DOI:10.1038/s41392-020-00446-7
PMID:33602893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7892549/
Abstract

Long non-coding RNAs (lncRNAs) play key roles in colorectal carcinogenesis. Here, we aimed to identify the risk SNP-induced lncRNAs and to investigate their roles in colorectal carcinogenesis. First, we identified rs6695584 as the causative SNP in 1q41 locus. The A>G mutation of rs6695584 created a protein-binding motif of BATF, altered the enhancer activity, and subsequently activated lncSLCC1 expression. Further validation in two independent CRC cohorts confirmed the upregulation of lncSLCC1 in CRC tissues, and revealed that increased lncSLCC1 expression was associated with poor survival in CRC patients. Mechanistically, lncRNA-SLCC1 interacted with AHR and transcriptionally activated HK2 expression, the crucial enzyme in glucose metabolism, thereby driving the glycolysis pathway and accelerating CRC tumor growth. The functional assays revealed that lncSLCC1 induced glycolysis activation and tumor growth in CRC mediated by HK2. In addition, HK2 was upregulated in colorectal cancer tissues and positively correlated with lncSLCC1 expression and patient survival. Taken together, our findings reveal a risk SNP-mediated oncogene lncRNA-SLCC1 promotes CRC through activating the glycolysis pathway.

摘要

长链非编码 RNA(lncRNAs)在结直肠癌的发生发展中起着关键作用。在这里,我们旨在鉴定风险 SNP 诱导的 lncRNAs,并研究它们在结直肠癌发生发展中的作用。首先,我们确定 1q41 位点上的 rs6695584 是致病 SNP。rs6695584 的 A>G 突变创造了 BATF 的蛋白结合基序,改变了增强子活性,随后激活了 lncSLCC1 的表达。在两个独立的 CRC 队列中的进一步验证证实了 lncSLCC1 在 CRC 组织中的上调,并表明 lncSLCC1 表达的增加与 CRC 患者的不良预后相关。在机制上,lncRNA-SLCC1 与 AHR 相互作用,并转录激活 HK2 的表达,HK2 是葡萄糖代谢中的关键酶,从而驱动糖酵解途径并加速 CRC 肿瘤的生长。功能测定表明,lncSLCC1 通过 HK2 在 CRC 中诱导糖酵解激活和肿瘤生长。此外,HK2 在结直肠癌组织中上调,并与 lncSLCC1 的表达和患者的生存呈正相关。总之,我们的研究结果揭示了一种风险 SNP 介导的致癌基因 lncRNA-SLCC1 通过激活糖酵解途径促进 CRC 的发生发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/8efcad930589/41392_2020_446_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/e583801a24dc/41392_2020_446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/606ac4fcc792/41392_2020_446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/e5787ecbbcfc/41392_2020_446_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/95786adec603/41392_2020_446_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/d4bae739b51a/41392_2020_446_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/8efcad930589/41392_2020_446_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/e583801a24dc/41392_2020_446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/606ac4fcc792/41392_2020_446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/e5787ecbbcfc/41392_2020_446_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/95786adec603/41392_2020_446_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/d4bae739b51a/41392_2020_446_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91aa/7892549/8efcad930589/41392_2020_446_Fig6_HTML.jpg

相似文献

[1]
Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling.

Signal Transduct Target Ther. 2021-2-19

[2]
Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2.

Aging (Albany NY). 2020-6-21

[3]
LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.

Clin Cancer Res. 2018-6-18

[4]
lncARSR sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis.

Cancer Sci. 2020-9-2

[5]
Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.

Biomed Pharmacother. 2017-11-6

[6]
targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.

Gut. 2021-11

[7]
LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.

Biomed Pharmacother. 2017-7-20

[8]
The long noncoding RNA CTA-941F9.9 is frequently downregulated and may serve as a biomarker for carcinogenesis in colorectal cancer.

J Clin Lab Anal. 2019-7-25

[9]
LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.

J Exp Clin Cancer Res. 2018-9-10

[10]
Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.

Biomed Pharmacother. 2018-8-9

引用本文的文献

[1]
HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis.

Biomolecules. 2025-4-28

[2]
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Cell Death Discov. 2025-3-3

[3]
Exploring the Link Between Noncoding RNAs and Glycolysis in Colorectal Cancer.

J Cell Mol Med. 2025-2

[4]
The diagnostic and prognostic significance of HOXC13-AS and its molecular regulatory mechanism in human cancer.

Front Mol Biosci. 2025-2-6

[5]
Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.

Transl Oncol. 2024-12

[6]
Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key.

Front Immunol. 2024

[7]
A functional variant rs10409772 in FUT6 promoter regulates colorectal cancer progression through PKA/CREB signaling.

Transl Oncol. 2024-8

[8]
The potential of aryl hydrocarbon receptor as receptors for metabolic changes in tumors.

Front Oncol. 2024-2-16

[9]
Global research trends and prospects of cellular metabolism in colorectal cancer.

World J Gastrointest Oncol. 2024-2-15

[10]
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.

Cell Death Dis. 2024-2-24

本文引用的文献

[1]
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma.

PeerJ. 2020-4-10

[2]
mA-dependent glycolysis enhances colorectal cancer progression.

Mol Cancer. 2020-4-3

[3]
SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression.

Oncogene. 2020-3-30

[4]
SNP rs12982687 affects binding capacity of lncRNA UCA1 with miR-873-5p: involvement in smoking-triggered colorectal cancer progression.

Cell Commun Signal. 2020-3-6

[5]
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.

Gut. 2020-10

[6]
A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90.

Oncogene. 2019-10-22

[7]
Integrated bioinformatics analysis revealing independent prognostic long non-coding RNAs DNAH17-AS1 and RP11-400N13.2 and their potential oncogenic roles in colorectal cancer.

Oncol Lett. 2019-10

[8]
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.

Nat Commun. 2019-8-2

[9]
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.

Gastroenterology. 2018-12-6

[10]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索